The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
Research on CAR T cells has achieved enormous progress in recent years. After the impressive results obtained in relapsed and refractory B-cell acute lymphoblastic leukemia and aggressive B-cell lymphomas, two constructs, tisagenlecleucel and axicabtagene ciloleucel, were approved by FDA. The role o...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , |
|---|---|
| Format: | Revisão |
| Jezik: | engleski |
| Izdano: |
2020
|
| Online pristup: | https://doi.org/10.3389/fimmu.2020.00888 https://www.frontiersin.org/articles/10.3389/fimmu.2020.00888/pdf |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|